To CANCER IMMUNITY Home Page

Table 1

 

Recognition of Melan-A peptides and tumor cell lines by DR monospecific populations.

 

Peptide recognitiona

Tumor recognitionb

MFIc

Melan-A27-35

Melan-A26-35

Melan-A26-35 A27L

NA8

NA8 + P

Me 275

Me 275 + P

Me 260

Me 260 + P

Melan-A26-35 A27L

Tyrosinase368-376

Bulk DR

20

10

0.006

76

71

72

60

11

9

437

4

DR/A1B4

2.5

1

0.002

80

88

82

87

5

6

630

3

DR/A1B9

30

100

0.5

80

77

72

75

4

0

277

3

DR/A1D3

>1000

>1000

0.5

70

95

47

100

4

3

239

3

DR/A1E1

8

8

0.02

72

82

70

80

7

6

466

3

DR/A1E2

>1000

>1000

0.2

71

66

60

60

3

3

83

3

DR/A2B4

>1000

>1000

0.03

18

65

23

69

0

1

605

4

DR/A2B5

3

0.2

0.003

85

85

78

74

10

8

326

3

DR/A2D6

>1000

>1000

0.2

19

52

10

39

0

3

818

4

LAU 203/17

5

5

0.02

5

90

81

85

3

4

428

4

aPeptide concentration (nM) required for 50% maximal lysis.
bSpecific lysis of NA8 (A2+ Melan-A-), Me 275 (A2+ Melan-A+), Me 260 (A2- Melan-A+) tumor cell lines at an E:T ratio of 50:1.
cMean fluorescence intensity with A2/peptide multimers incorporating the Melan-A26-35 A27L or Tyrosinase368-376 peptides.

 

Copyright © 2002 by Danila Valmori